Researcher Profile

Researcher Profile

Diane Hershock, MD, PhD

Diane Hershock, MD, PhD

Associate Professor, Department of Medicine
Division of Hematology and Oncology
Scientific Program:Experimental Therapeutics
Disease Teams:
Head and Neck Cancer
Melanoma and Skin Cancer
dmh58@psu.edu

Research Interests

  • Radiotherapy
  • Blood Platelets
  • Therapeutics
  • Head and Neck Neoplasms
  • Neoplasms
  • Fibrinogen
  • Survival
  • Drug Therapy
  • Organ Preservation
  • Radiation Oncology
  • Chymotrypsin
  • Erythropoietin

Clinical Trials

A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrent Disease in Cutaneous Squamous Cell Carcinoma

Recent Publications

2016

Nijenhuis, CM, Hellriegel, E, Beijnen, JH, Hershock, D, Huitema, ADR, Lucas, L, Mergui-Roelvink, M, Munteanu, M, Rabinovich-Guilatt, L, Robertson, P, Rosing, H, Spiegelstein, O & Schellens, JHM 2016, 'Pharmacokinetics and excretion of 14C-omacetaxine in patients with advanced solid tumors', Investigational New Drugs, vol. 34, no. 5, pp. 565-574. https://doi.org/10.1007/s10637-016-0360-9

2015

Shenouda, G, Zhang, Q, Ang, KK, Machtay, M, Parliament, MB, Hershock, D, Suntharalingam, M, Lin, A, Rotman, M, Nabid, A, Hong, S, Shehata, S, Cmelak, AJ, Sultanem, K & Le, QT 2015, 'Long-term results of radiation therapy oncology group 9903: A randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck' International Journal of Radiation Oncology Biology Physics, vol. 91, no. 5, pp. 907-915. https://doi.org/10.1016/j.ijrobp.2014.12.018

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)